JPMorgan (JPM) prices $5M S&P 500 capped accelerated notes due 2031
Rhea-AI Filing Summary
JPMorgan Chase Financial Company LLC priced $5,000,000 of Capped Accelerated Barrier Notes linked to the S&P 500® Index. The notes priced on May 6, 2026 and are expected to settle on or about May 11, 2026. They mature on October 17, 2031 and have a maximum return of 81.5992% (a maximum payment of $1,815.992 per $1,000 principal). The Initial Value and Final Value are each the arithmetic average of specified Initial Averaging Dates and Ending Averaging Dates. The structure uses an Upper Barrier of 86.00% and a Lower Barrier of 72.00% of the Initial Value and applies specified upside and downside leverage factors to determine payment at maturity. The notes are unsecured obligations of JPMorgan Chase Financial and are fully and unconditionally guaranteed by JPMorgan Chase & Co.; payments remain subject to issuer and guarantor credit risk.
Positive
- None.
Negative
- None.
Insights
Mechanics: capped accelerated barrier payoff with averaging and explicit barrier thresholds.
The notes provide a capped upside and asymmetric downside tied to the arithmetic-average Initial and Ending Averaging Dates. Key parameters include a Maximum Return 81.5992%, Upper Barrier 86.00%, Lower Barrier 72.00%, and leverage factors of 0.7631, 1.4295 and 2.00. The Initial and Final Values are averaging-based, which materially affects payoff timing and threshold outcomes.
Dependencies include index performance on many averaging dates and issuer/guarantor creditworthiness. Secondary market liquidity is limited and repurchase pricing may be below issue price; the documents note an initial period where JPMS may publish higher account values. Subsequent account statements and market movements will determine realized outcomes.
Tax treatment is opinion-based and contingent on IRS interpretation.
Special tax counsel concludes it is reasonable to treat the notes as open transactions and not debt, so gains held over one year would be long-term capital gain. That treatment is an opinion and the IRS or a court may disagree, which could materially change timing and character of income.
Section 871(m) considerations are addressed; the issuer and counsel state they expect Section 871(m) not to apply to these notes for Non-U.S. Holders, but that determination is not binding on the IRS. Holders should consult tax advisers.